当前位置: 首页 > 详情页

Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine

文献详情

资源类型:
机构: [a]Peking Union Medical College Hospital, Beijing 100730, China [b]Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, China [c]National Center of Nanoscience and Technology, Beijing 100080, China [d]Institute of Physics, Chinese Academy of Sciences, Beijing 100080, China [e]Beijing TianTan Hospital, Beijing 100050, China
出处:
ISSN:

关键词: Aluminum Anticancer Immune adjuvant Nanoparticle

摘要:
The application of nanomaterial in cancer treatment is promising and intriguing. Anti-tumor immunotherapy has the potential to significantly improve the prognosis of cancer treatment, though the efficacy of immunotherapy generally needs further improvement. One way to improve the efficacy is using immune adjuvants, but the adjuvants for anticancer immunotherapy have to be more potent than for prophylactic vaccines. Here, we report that compared to conventional alum adjuvant, aluminum oxide nanoparticles (nano-alum) may further enhance the anticancer effects of an immunotherapy that employs tumor cell vaccine (TCV). The average tumor size tends to be lower in animals that receive the combinational treatment of nano-alum and TCV. The anticancer cytotoxicity by the lymphocytes was also significantly higher in the treatment group that received both TCV and nano-alum. These results suggest that nano-alum may potentially serve as a potent immune adjuvant and have prospective applications in anticancer immunotherapy. © Springer-Verlag 2010.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
最新[2023]版:
大类 | 2 区 工程技术
小类 | 3 区 纳米科技 3 区 肿瘤学
第一作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院